BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38192097)

  • 21. Artificial intelligence for predicting survival following deceased donor liver transplantation: Retrospective multi-center study.
    Yu YD; Lee KS; Man Kim J; Ryu JH; Lee JG; Lee KW; Kim BW; Kim DS;
    Int J Surg; 2022 Sep; 105():106838. PubMed ID: 36028137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver Transplant Survival Index for Patients with Model for End-Stage Liver Disease Score ≥ 35: Modeling Risk and Adjusting Expectations in the Share 35 Era.
    Steggerda JA; Kim IK; Todo T; Malinoski D; Klein AS; Bloom MB
    J Am Coll Surg; 2019 Apr; 228(4):437-450.e8. PubMed ID: 30594593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Assessment in High- and Low-MELD Liver Transplantation.
    Schlegel A; Linecker M; Kron P; Györi G; De Oliveira ML; Müllhaupt B; Clavien PA; Dutkowski P
    Am J Transplant; 2017 Apr; 17(4):1050-1063. PubMed ID: 27676319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center.
    Agopian VG; Petrowsky H; Kaldas FM; Zarrinpar A; Farmer DG; Yersiz H; Holt C; Harlander-Locke M; Hong JC; Rana AR; Venick R; McDiarmid SV; Goldstein LI; Durazo F; Saab S; Han S; Xia V; Hiatt JR; Busuttil RW
    Ann Surg; 2013 Sep; 258(3):409-21. PubMed ID: 24022434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Acuity Circles on Deceased Donor Transplant and Offer Rates Across Model for End-Stage Liver Disease Scores and Exception Statuses.
    Wey A; Noreen S; Gentry S; Cafarella M; Trotter J; Salkowski N; Segev D; Israni A; Kasiske B; Hirose R; Snyder J
    Liver Transpl; 2022 Mar; 28(3):363-375. PubMed ID: 34482614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.
    Jiang L; Yan L; Tan Y; Li B; Wen T; Yang J; Zhao J
    Surg Today; 2013 Sep; 43(9):1039-48. PubMed ID: 23467980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of liver transplantation from old donors.
    Dudek K; Kornasiewicz O; Remiszewski P; Zieniewicz K; Wróblewski T; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2762-5. PubMed ID: 25380912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y; Wang Q; Yang J; Yan L
    PLoS One; 2015; 10(9):e0136604. PubMed ID: 26378786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End-Stage Liver Disease Scores <30.
    Kitajima T; Moonka D; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Nagai S
    Liver Transpl; 2021 Jul; 27(7):971-983. PubMed ID: 33492764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States.
    Muhammad H; Gurakar M; Ting PS; Alsughayer AM; Luu H; Zaffar D; Alqahtani S; Bonder A; Gurakar A; Saberi B
    Exp Clin Transplant; 2022 Mar; 20(3):279-284. PubMed ID: 35352634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Liver Transplant Justified at Any MELD Score?
    Oden-Brunson H; McDonald MF; Godfrey E; Keeling SS; Cholankeril G; Kanwal F; O'Mahony C; Goss J; Rana A
    Transplantation; 2023 Mar; 107(3):680-692. PubMed ID: 36367923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of donor sex on hepatocellular carcinoma recurrence in liver transplantation after brain death.
    Nakamura T; Sasaki K; Kojima L; Teo R; Inaba Y; Yamamoto T; Kimura S; Dageforde LA; Yeh H; Elias N; Bozorgzadeh A; Kawai T; Markmann JF
    Clin Transplant; 2023 Aug; 37(8):e14989. PubMed ID: 37039506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
    Matoba D; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Doki Y; Eguchi H
    Transplant Proc; 2023 May; 55(4):893-897. PubMed ID: 37120341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is living donor liver transplantation justified in high model for end-stage liver disease candidates (35+)?
    Au KP; Chan ACY
    Curr Opin Organ Transplant; 2019 Oct; 24(5):637-643. PubMed ID: 31408016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
    Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
    Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.